Microcirculation of Patients With Kidney Transplant

Microcirculation Clinical Trial

Official title:

Sublingual Microcirculation Data of Patients With Kidney Transplant

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02874781
• Other study ID #: 201605035RINC
• Status: Completed
• Phase: N/A
• First received: August 5, 2016
• Last updated: December 12, 2016
• Start date: July 2016
• Est. completion date: October 2016

Study information

• Verified date: December 2016
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Ministry of Health and Welfare
• Study type: Observational

Clinical Trial Summary

This study measures the sublingual microcirculation of patients with kidney transplant using MicroScan. The data will be compared with data of health volunteers and end stage renal disease patients on hemodialysis.

Description:

This study measures the sublingual microcirculation of patients with kidney transplant using MicroScan. The data will be compared with data of health volunteers and end stage renal disease patients on hemodialysis. The microcirculation date includes total small vessel density, perfused small vessel density, proportion of perfused vessels, microvascular flow index, and heterogeneity index.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: October 2016
• Est. primary completion date: October 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 79 Years

Eligibility

Inclusion Criteria:

• patients with kidney transplant for more than one month

Exclusion Criteria:

• Body mass index (BMI) < 18.5 or > 30

• diagnosis of sepsis or trauma, or admitted to intensive care unit within one month before enrollment

• body temperature < 35.5 or > 37.5 Celsius

• patients with tongue resection

• non-native speaker

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Microcirculation

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Total small vessel density		6 hours	No
Primary	Perfused small vessel density		6 hours	No